Bram Harmsen

Title: The Innovative Contributions of Bram Harmsen

Introduction: Bram Harmsen is a notable inventor based in Munich, Germany, recognized for his significant contributions to the field of pharmaceutical science. With a strong focus on crystalline forms of pharmacological compounds, Bram has been instrumental in advancing the understanding and application of fasoracetam, a compound with potential therapeutic benefits.

Latest Patents: Bram Harmsen holds three patents, with his latest innovations centered around the crystalline forms of fasoracetam. His first patent involves the disclosure of R-fasoracetam crystalline forms, specifically Form II monohydrate and its anhydrate counterpart. Additionally, he explores mixtures of these forms. His second patent expands on this research by presenting cocrystals of fasoracetam, including R-fasoracetam, along with various coformers. This work includes the provision of pharmaceutical compositions and methods for treating using these cocrystals and crystalline materials.

Career Highlights: Currently, Bram Harmsen is affiliated with the Children’s Hospital of Philadelphia, where his work bridges the gap between innovative research and practical application in pediatric health care. His role in the formulation and development of novel pharmaceutical products has positioned him as a prominent figure in his field.

Collaborations: Bram collaborates with talented professionals such as Tom Leyssens and Richard Alan Couch, contributing to a dynamic research environment. Together, they work towards pushing the boundaries of medical science and improving treatment options for patients.

Conclusion: Bram Harmsen exemplifies the spirit of innovation through his patents and collaborations. His commitment to researching and developing new pharmaceutical formulations, particularly in the realm of fasoracetam, showcases his significant contributions to the field, and his work holds promise for future advancements in medical treatments.